A Randomized, Open-Label, Crossover, Drug Interaction Study to Evaluate the Effects of DVS SR And Duloxetine on the Pharmacokinetics of Desipramine in Healthy Subjects

Wyeth is now a wholly owned subsidiary of Pfizer1 个研究点分布在 1 个国家目标入组 20 人开始时间: 2006年9月1日最近更新: 2007年5月28日

适应症

试验速览

阶段: 3 期
状态: 已完成
发起方
入组人数: 20
试验地点: 1
主要终点: The primary outcome of the study is to evaluate the effects of multiple doses of DVS SR and duloxetine on the pharmacokinetics of a single dose of desipramine in healthy subjects.

研究概览研究设计入排标准结局指标研究者研究点记录与标识符相似试验

研究概览

简要总结

The purpose of this study is to evaluate the effects of multiple doses of DVS SR and duloxetine on the pharmacokinetics of a single dose of desipramine in healthy subjects.

研究设计

研究类型: Interventional
分配方式: Randomized
干预模型: Crossover
主要目的: Treatment
盲法: None

入排标准

年龄范围: 18 Years 至 55 Years（Adult）
性别: All
接受健康志愿者: 是

入选标准

•Healthy men and women between 18 to 55 years of age.
•Healthy as determined by the investigator on the basis of medical history and physical examination, laboratory test results, vital signs and a 12-lead electrocardiogram.
•History of being a nonsmoker for a least 1 year.

排除标准

未提供

结局指标

主要结局

The primary outcome of the study is to evaluate the effects of multiple doses of DVS SR and duloxetine on the pharmacokinetics of a single dose of desipramine in healthy subjects.

次要结局

未报告次要终点

研究者

发起方

Wyeth is now a wholly owned subsidiary of Pfizer

申办方类型

Industry

研究点 (1)

Loading locations...

相似试验

已完成

3 期

Study Evaluating the Effects of DVS SR and Paroxetine on the Pharmacokinetics of Desipramine in Healthy SubjectsDepression

NCT00329147Wyeth is now a wholly owned subsidiary of Pfizer20

已完成

4 期

Study Evaluating the Effect of Desvenlafaxine on the Pharmacokinetics of MidazolamMajor Depressive Disorder

NCT00952653Pfizer28

已完成

1 期

Interaction Between Duloxetine and 3,4-Methylenedioxymethamphetamine (MDMA, Ecstasy)Substance-Related DisordersAmphetamine-Related DisordersMood Disorder

NCT00990067University Hospital, Basel, Switzerland16

已完成

3 期

Study Evaluating the Efficacy and Safety of Desvenlafaxine Tablets in Adult Outpatients With Major Depressive DisorderDepressive Disorder, Major

NCT00300378Wyeth is now a wholly owned subsidiary of Pfizer480

已完成

3 期

Study of the Safety and Efficacy of Desvenlafaxine Succinate for Vasomotor Symptoms in Postmenopausal WomenVasomotor SystemMenopause

NCT00369434Wyeth is now a wholly owned subsidiary of Pfizer450